NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djae221 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Nikolaus Christian Simon Mezger und 25 weiteren Autor:innen. Beteiligte Einrichtung: Global and Planetary Health Working Group, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Witten…. Hauptthemen laut MEDLINE: Guideline Adherence, Neoplasms, Practice Guidelines as Topic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research, Developing Excellence in Leadership, Training and Science in Africa, American Cancer Society.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
To assess population-based quality of cancer care in sub-Saharan Africa and to identify specific gaps and joint opportunities, we assessed concordance of diagnostics and treatments with National Comprehensive Cancer Network Harmonized Guidelines for leading cancer types in 10 countries.
Methods
Adult patients with female breast cancer, cervical cancer, colorectal cancer, non-Hodgkin lymphoma, and prostate cancer were randomly drawn from 11 population-based cancer registries. Guideline concordance of diagnostics and treatment was assessed using clinical records. In a subcohort of 906 patients with potentially curable cancer (stage I-III breast cancer, cervical cancer, colorectal cancer, prostate cancer, aggressive non-Hodgkin lymphoma [any stage]) and documentation for more than 1 month after diagnosis, we estimated factors associated with guideline-concordant treatment or minor deviations.
Results
Diagnostic information based on guidelines was complete for 1030 (31.7%) of a total of 3246 patients included. In the subcohort with curable cancer, guideline-concordant treatment was documented in 374 (41.3%, corresponding to 11.7% of 3246 patients included in the population-based cohort): aggressive non-Hodgkin lymphoma (59.8%/9.1% population based), breast cancer (54.5%/19.0%), prostate cancer (39.0%/6.1%), colorectal cancer (33.9%/9.5%), and cervical cancer (27.8%/11.6%). Guideline-concordant treatment was most frequent in Namibia (73.1% of the curable cancer subcohort/32.8% population based) and lowest in Kampala, Uganda (13.5%/3.1%). Guideline-concordant treatment was negatively associated with poor ECOG-ACRIN performance status, locally advanced disease stage, origin from low Human Development Index countries, and a diagnosis of colorectal cancer or cervical cancer.
Conclusions
The quality of diagnostic workup and treatment showed major deficits, with considerable disparities among countries and cancer types. Improved diagnostic services are necessary to increase the share of curable cancer in sub-Saharan Africa. Treatment components within National Comprehensive Cancer Network Guidelines for several cancers should be prioritized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Global and Planetary Health Working Group, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle, Germany.
- Global Public Health Department, Karolinska Institutet, Stockholm, Sweden.
- Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty at Heinrich-Heine-University, Duesseldorf, Germany.
- African Cancer Registry Network, Oxford, UK.
- Dr AB May Cancer Care Centre, Windhoek Central Hospital, Windhoek, Namibia.
- Registre des cancers de Bamako, Bamako, Mali.
ORCID-Profile: Nikolaus Christian Simon Mezger, Anne Korir, Rafael Mikolajczyk, Donald Max Parkin, Ahmedin Jemal, Eva Johanna Kantelhardt
Förderung
- German Federal Ministry of Education and Research
- Developing Excellence in Leadership, Training and Science in Africa
- American Cancer Society
- Science for Africa Foundation
- Foreign, Commonwealth & Development Office
- World Health Organization
- Wellcome Trust
- German Ministry for Economic and Development Cooperation
Zitieren
APA
Mezger, N. C. S., Seraphin, T. P., Ballé, R., Griesel, M., Joko-Fru, Y. W., Hämmerl, L., Feuchtner, J., Liu, B., Zietsman, A., Kamaté, B., Gnangnon, F. H. R., Gnahatin, F., Mboungou, D. M., Assefa, M., Amulen, P. M., Chesumbai, G., Chingonzoh, T., Lorenzoni, C. F., Korir, A., …, & Kantelhardt, E. J. (2025). NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae221
Vancouver
Mezger NCS, Seraphin TP, Ballé R, Griesel M, Joko-Fru YW, Hämmerl L, et al. NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae221
BibTeX
@article{Mezger2025,
author = {Mezger, Nikolaus Christian Simon and Seraphin, Tobias Paul and Ballé, Robert and Griesel, Mirko and Joko-Fru, Yvonne Walburga and Hämmerl, Lucia and Feuchtner, Jana and Liu, Biying and Zietsman, Annelle and Kamaté, Bakarou and Gnangnon, Freddy Houéhanou Rodrigue and Gnahatin, Franck and Mboungou, Dimitry Moudiongui and Assefa, Mathewos and Amulen, Phoebe Mary and Chesumbai, Gladys and Chingonzoh, Tatenda and Lorenzoni, Cesaltina Feirreira and Korir, Anne and Carvalho Santos, Pablo S and Mezger, Jörg Michael and Al-Ali, Haifa Kathrin and Mikolajczyk, Rafael and Parkin, Donald Max and Jemal, Ahmedin and Kantelhardt, Eva Johanna},
title = {NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djae221}
}
EUVIMED